CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lantheus Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lantheus Holdings Inc
331 Treble Cove Rd
Phone: (978) 671-8001p:978 671-8001 NORTH BILLERICA, MA  01862  United States Ticker: LNTHLNTH
Business Summary
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. The Company's product categories include Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Others. The Company's Radiopharmaceutical Oncology products help healthcare professionals (HCPs) find, fight and follow cancer. The Company's Precision Diagnostic products assist HCPs to find and follow diseases. Its Strategic Partnerships include biomarkers and digital solutions in support of its partners’ therapeutic development, out-licensing agreements for non-core assets and optimization of its assets geographically. The Company's commercial products are used by cardiologists, internal medicine physicians, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists working in a variety of clinical settings.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024YesYes--Yes

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
3844 X-ray apparatus and tubes and related irradiation apparatus
2835 In vitro and in vivo diagnostic substances
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Interim Executive Officer Mary A.Heino 65 1/1/2026 4/1/2013
Chief Financial Officer, Treasurer Robert J.Marshall 58 9/24/2018 9/24/2018
Chief People Officer JamieSpaeth 43 7/8/2024 7/8/2024
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
EXCELSIOR LIFE SCIENCES IRELAND LIMITED 25/28 NORTH WALL QUAY DUBLIN 1DUBLIN Ireland
LANTHEUS MI UK LIMITED ASHCOMBE COURT WOOLSACK WAY, GODALMING, UK
LANTHEUS EU LIMITED ROCKTWIST HOUSE BLOCK 1 WESTERN BUSINESS PARK IE
9 additional Subsidiary records available in full report.

Business Names
Business Name
Aphelion LLC
Cerveau Technologies, Inc.
Evergreen Theragnostics, Inc.
24 additional Business Names available in full report.

General Information
Number of Employees: 808 (As of 12/31/2024)
Outstanding Shares: 66,311,779 (As of 11/3/2025)
Shareholders: 29
Stock Exchange: NASD
Federal Tax Id: 352318913
Fax Number: (302) 636-5454


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 14, 2026